Zevra’s Leading Drug Candidate for Idiopathic Hypersomnia Treatment Advancing
The company also announced plans to begin a search for a new CEO to succeed Richard W. Pascoe, who will retire on June 1.
The company also announced plans to begin a search for a new CEO to succeed Richard W. Pascoe, who will retire on June 1.